Can a wearable predict prolonged sitting for people with chronic pelvic pain?
A peer-reviewed study used Fitbit data from 134 participants to forecast sedentary periods one hour ahead. It demonstrates a modelling pipeline—not that prompts improve pain, activity or health outcomes.
The short version
- What happened
- The study analysed Fitbit data from 134 participants with chronic pelvic pain disorders: 19 in a tuning cohort and 115 in the main evaluation cohort, plus a separate 61-person healthy control cohort.
- Who it affects
- People with chronic pelvic pain could eventually receive fewer, better-timed movement prompts, but the system has not yet shown that it improves symptoms or activity.
- What remains unproven
- This is a secondary analysis of observational Fitbit data rather than a randomised trial of prompts or a treatment study.
Keep in mind
This is a secondary analysis of observational Fitbit data rather than a randomised trial of prompts or a treatment study.
Only participants with sufficient valid wearable data entered the main evaluation, which may favour people able to wear and sync the device consistently.
The work does not establish generalisability across countries, consumer devices, genders, disabilities or clinical settings.
Source analysis · 2 linked sources. Primary analysed source date: 30 September 2026.
Read the full report · 5 min The evidence, methods, implications and limitations
The study forecast behaviour; it did not test a treatment
Researchers at Mount Sinai and Columbia used minute-level Fitbit data to forecast periods of sedentary behaviour among participants with chronic pelvic pain disorders. The peer-reviewed paper was published on 30 September in npj Women's Health. Its practical aim is a future system that could recognise when someone is likely to remain inactive and send a timely prompt, rather than issue generic reminders throughout the day. The present study stops before that intervention: it evaluates prediction from recorded behaviour and does not deliver prompts or measure whether anyone moves more as a result.
The parent observational study collected daily and weekly information for 90 days using Fitbit Inspire 2 trackers. Eligible participants were assigned female at birth, menstruating, aged 18 to 64, reported a surgical or clinician diagnosis of a chronic pelvic pain disorder and had experienced pain for at least six months. The modelling analysis used 134 participants: 19 with at least 90% data completeness formed the tuning cohort, while 115 with sufficient valid data formed the evaluation cohort. A separate 61-person healthy control cohort was used for an additional consistency check.[1][2]
Recent activity and daily routine carried most of the signal
The team translated Fitbit activity levels into a physical activity score and compared an adaptive recursive least-squares model with two offline approaches: SARIMA, a statistical time-series model, and an LSTM neural network. All three beat simple mean and persistence baselines for one-hour-ahead forecasting. In the 115-person evaluation cohort, median root-mean-square error was 0.090 for SARIMA, 0.091 for recursive least squares and 0.095 for the LSTM. Those small differences led the researchers to favour the adaptive model because it can update on-device without repeated central retraining.
For 15-minute sedentary bouts, the authors report an operating point of roughly one true alert a day alongside 0.6 false alerts. That is a model-selected trade-off, not a patient-tested tolerance. A reminder system that interrupts someone during pain, work, travel or sleep may create burden even when the prediction is technically correct. Conversely, an alert can be missed precisely when pain makes movement difficult. The study therefore establishes that timing information can be extracted from these wearable traces; it does not establish which alert threshold is acceptable or helpful in daily life.[1]
On-device learning could protect privacy, but the device still defines the data
Participant-specific learning can reduce the need to pool raw activity traces in a central service. The chosen adaptive model is deliberately lightweight and could update locally as routines change. That design is relevant because continuous movement, heart-rate and sleep data can reveal sensitive patterns about work, home life and health. Genuine privacy, however, depends on the full product architecture: where raw data are stored, whether model updates leave the device, who can retrieve logs, how long records persist and whether a user can pause or delete the system.
The physical activity score also inherits limitations from the Fitbit measurements used to create it. The researchers treated minutes without heart-rate data as missing, aggregated activity into time bins and excluded evaluation participants without at least 480 valid hours. That improves stability but means the reported performance applies to people who generated enough usable data. People with poorer device fit, irregular wear, different mobility patterns or limited access to consumer wearables may experience different accuracy. The sample came from one research programme and does not demonstrate performance across countries, devices or clinical services.[1]
What patients should expect—and what would change our assessment
This work should not change treatment today. It does not diagnose chronic pelvic pain, recommend a safe activity level or show that reducing sitting improves symptoms for an individual. A future tool would need co-design with patients, clear advice for pain flares and clinical review of who should not receive movement prompts. It should also distinguish a prediction from a medical instruction and let users control timing, intensity and data sharing. Accessibility matters: a system that assumes every user can respond by walking may exclude people with disability, fatigue or severe pain.
Our assessment would strengthen after a prospective trial randomises people to model-timed prompts, simpler scheduled reminders or no prompts and measures sedentary time, pain, function, adherence, unwanted interruptions and dropout. External validation on other wearables and more diverse populations would show whether the signal transfers. It would weaken if real-time deployment produces substantially more false alerts, if benefits disappear outside the observed sample or if prompts worsen pain or anxiety. For now, this is a credible forecasting study and a design candidate—not evidence of a clinically effective digital intervention.[1][2]